Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737358 · ClinicalTrials.gov registry record · Phase 2
N-acetylcysteine for Tobacco Use Disorder
A Phase 2 study of Smoking and Nicotine Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT02737358 is a Phase 2 study of Smoking and Nicotine Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 114 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02737358, a Phase 2 study of Smoking and Nicotine Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG N-acetylcysteine (NAC)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2016-08-30 |
| Est. Completion | 2019-10-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02737358
The ClinicalTrials.gov registry entry for NCT02737358 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (75% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02737358 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02737358 about?
NCT02737358 is a clinical study titled "N-acetylcysteine for Tobacco Use Disorder". The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.
What is the current status of trial NCT02737358?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2016-08-30. Estimated completion is 2019-10-10.
What conditions does trial NCT02737358 study?
This clinical trial studies the following conditions: Smoking, Nicotine Dependence.
What interventions are being tested in trial NCT02737358?
The interventions under investigation include: Placebo (OTHER), N-acetylcysteine (NAC) (DRUG).
Who is sponsoring clinical trial NCT02737358?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737358 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
RECRUITING · Phase 2
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
RECRUITING · Phase 2
-
App for Reducing Cravings to Smoke
RECRUITING · Phase 2
-
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
ACTIVE NOT RECRUITING · Phase 2
-
Proactive Health Intervention for Tobacco Users (Get PHIT)
COMPLETED · Phase 2
-
Computer-Assisted Intervention for Smoking During Pregnancy
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.